Objectives: To determine macrolide-lincosamide-streptogramin (MLS) resistance determinants in the Capnocytophaga genus and to describe the prevalence of b-lactam resistance genes in human oral Capnocytophaga species.
Introduction
The genus Capnocytophaga encompasses a group of fastidious capnophilic/facultatively anaerobic Gram-negative bacilli. 1 Species from the human oral microbiota (Capnocytophaga ochracea, Capnocytophaga sputigena, Capnocytophaga gingivalis, Capnocytophaga granulosa, Capnocytophaga leadbetteri and Capnocytophaga haemolytica) are associated with varying degrees of periodontal health or disease and are responsible for a number of opportunistic infections. 1 -3 An epidemiological study of carriage and species distribution according to clinical context is necessary. 1, 3, 4 Handal et al. 5 reported that bla CfxA2 and bla CfxA3 were responsible for the extended-spectrum resistance to b-lactam antibiotics in Capnocytophaga spp. Recently, a new b-lactamase, CSP-1, produced by a clinical isolate of C. sputigena, has been characterized, 6 but the distribution and prevalence of the gene bla CSP-1 are currently unknown in Capnocytophaga spp. No data concerning resistance to macrolide -lincosamide -streptogramin (MLS) antibiotics are currently available for the Capnocytophaga genus.
The aims of the present study were to identify the determinants of MLS resistance and to analyse the phenotypic expression, distribution and prevalence of b-lactamases (including CSP-1) and MLS resistance genes in Capnocytophaga species according to clinical context. sampled from 14 haematology patients (HPs) undergoing a course of chemotherapy for cancer, and 11 isolates were taken from 11 periodontitis patients (PPs) treated in the dental outpatient department. In addition, a study was conducted to evaluate the oral presence of Capnocytophaga spp. from healthy volunteers (HVs) without medical or oral pathology and without prior or concomitant exposure to b-lactam or MLS antibiotics. Nineteen isolates were sampled from 17 HVs. The composition of the groups (age and sex) and the exposure of all patients and volunteers to antimicrobial agents prior to (6 months) or during the conduct of the study are indicated in Table S1 (available as Supplementary data at JAC Online). All participants provided written informed consent in accordance with local ethics committee requirements. Subgingival plaque was collected as previously described. 7 The samples were serially diluted and inoculated into blood agar medium (Bio-Rad Laboratories, Marnes-la-Coquette, France), bacitracin chocolate blood agar medium (Bio-Rad Laboratories), vancomycin-kanamycin medium (VK; Beckton Dickinson, Le Pont de Claix, France) and vancomycin -colistin -amphotericin B-trimethoprim medium (VCAT; Oxoid, Dardilly, France). All plates were kept for 3 days under 5% (v/v) CO 2 at 378C except blood agar and VK plates, which were incubated in an anaerobic atmosphere.
Bacterial species identification was performed by analysis of the 16S rRNA gene sequence. Briefly, a 16S rRNA gene fragment (1468 bp) was amplified by PCR and sequenced according to a previous study. 1 The Bioinformatics Bacterial Identification software (http://pbil.univ-lyon1.fr/ bibi/) was used for phylogenetic analysis and bacterial identification. For all isolates, MICs were determined by Etest as previously described, 5 for the following antibiotics: amoxicillin, amoxicillin/clavulanic acid, cefotaxime, ceftazidime, erythromycin and clindamycin. The presence of b-lactam (bla CfxA and bla CSP-1 ) and MLS [erm(F), erm(B), erm(C), erm(Q), erm(D) and erm(A)] resistance genes was assessed by PCR with specific primers (Table 1) , followed by subsequent sequencing. 8 DNA was amplified by PCR with an initial denaturation step at 948C for 5 min, followed by 30 s at the annealing temperature (Table 1) , then a final extension step at 728C for 7 min. We selected the MLS resistance genes to be included in this study by reviewing the literature on MLS resistance in anaerobes and oral flora 9, 10 and by analysing the phylogenetic relationships between methylases. The positive control strains used were as follows: Escherichia coli (pCAP01) for bla CfxA ; 8 C. sputigena strain 507 for bla CSP-1 (GenBank GQ919044.1); E. coli (pYK028) for erm(F); 11 E. coli (pJIR432) for erm(Q); 12 Staphylococcus aureus RN1389 for erm(A); 13 E. coli (pAT273) for erm(D); 14 Enterococcus faecalis (pJH1) for erm(B); 13 and S. aureus (pE194) for erm(C). 13 A negative control without template DNA was included in each experiment.
R software (R-2.15.0 for Microsoft Windows, http://www.R-project.org/) was used for statistical analysis of species and resistance marker distributions (Fisher's exact test). A P value of ,0.05 was considered to indicate statistical significance.
Results and discussion
The diversity of media used allowed isolation of Capnocytophaga spp. from every patient. Therefore, our present study, which focused on the Capnocytophaga genus, allowed us to estimate the carriage of these fastidious bacteria in adults and children, for the first time as 100%. In the literature, data regarding the isolation frequency of Capnocytophaga spp. from oral clinical samples are conflicting due to the different microbial procedures employed, and due to the fastidious growth of this bacterial genus in the rich oral microbiota. With the exception of C. haemolytica, all Capnocytophaga species were detected, including the new species C. leadbetteri. 1 The species distributions of the subject groups were significantly different (P,0.03; Table 2 ). C. ochracea was the main species (68%) detected in the HV group, consistent with its role in periodontal health. 3 In the PP group, C. sputigena was the main species isolated (64%; C. ochracea, 18%); C. granulosa and C. leadbetteri were also isolated. Samples from HPs included a more diversified species distribution (50% C. sputigena and 22% C. ochracea), with three additional species: C. gingivalis, C. granulosa and C. leadbetteri. In the HP and PP groups, the proportion of b-lactamase-producing isolates was high (50% and 82%, respectively) versus the HV group (16%; P,0.001; Table 2 ). Sixty-four percent of C. sputigena isolates were b-lactamase-positive versus 11% of C. ochracea isolates (P,0.001). Periodontitis is one of the most common chronic inflammatory diseases and may promote colonization by antibiotic-resistant resident bacteria. 7, 8 Ehrmann et al.
b-Lactamase-positive isolates were also found among more rarely identified species (C. leadbetteri, C. gingivalis and C. granulosa).
All b-lactamase-producing isolates (44%) were PCR-positive for bla CfxA (31%) or bla CSP-1 (12.5%). With Prevotella, 8 the Capnocytophaga genus constitutes the main source of b-lactam resistance genes in the oral microbiota. bla CfxA was more frequently detected than bla CSP-1 , probably due to its location on a plasmid (pCAP01 or other unrelated plasmid) or a transposon, such as in Bacteroides and Prevotella. 5, 8, 15 bla CSP-1 was identified only in a subgroup of C. sputigena species (P,0.05), which was PCR-negative for bla CfxA (Table 2 ). CfxA2, CfxA3 and CSP-1 b-lactamase-producing isolates presented high MIC 50 and MIC 90 values of amoxicillin, cefotaxime and ceftazidime (8 -64 and 64 -256 mg/L, respectively) and thus could easily be differentiated from b-lactamase-negative isolates (Table 3) . C. sputigena bla CfxA or bla CSP-1 isolates could not be differentiated by their phenotypic resistance patterns or 16S rRNA sequences. b-Lactamase-producing isolates remained susceptible to the combination of clavulanic acid and amoxicillin. The prevalence of MLS-resistant isolates was 21% -36%, independent of patient group, species or b-lactamase production ( Table 2) . MLS-resistant isolates presented equally high MIC 50 and MIC 90 values (256 mg/L) of erythromycin and clindamycin, suggesting constitutive MLS resistance (Table 3) . Resistance determinants unknown in Capnocytophaga spp. were sought by specific PCR. The majority of MLS-resistant isolates (13/14, 93%) were erm(F) PCR-positive with DNA sequences 100% identical to each other, harbouring the same Ile130Val substitution that is absent in the Bacteroides fragilis M14730 erm(F) sequence. 11 Horizontal gene transfer may occur in Capnocytophaga species and probably in the Bacteroides -Cytophaga -Flavobacterium branch of the eubacterial tree. 16, 17 Indeed, erm(F) genes are known to have a Antibiotic resistance genes in Capnocytophaga species 383 JAC broad host range that includes Treponema denticola. 9 The erm(F) gene was detected in all species (except C. granulosa), including the two C. leadbetteri isolates. One C. ochracea isolate that was highly resistant to erythromycin and clindamycin (256 mg/L) was erm(F) PCR-negative, but erm(C) PCR-positive with 100% nucleotide identities with erm(C) of S. aureus and 96% with Lactobacillus reuteri (GenBank FJ489650). All other erm methylase genes sought by PCR were not detected in Capnocytophaga spp. All Capnocytophaga isolates that were methylase PCR-negative were susceptible to erythromycin and clindamycin (0.38-1 and 0.016-1 mg/L, respectively). With a minimum prevalence of 21% methylaseproducing isolates, and in comparison with published studies, 10 we showed that Capnocytophaga spp. constitute the main reservoir of MLS genes in the oral cavity. This work did not allow demonstration of a link between the prevalence of resistant Capnocytophaga isolates and antibiotherapy during the last 6 months, or hospitalization (HP group of inpatients versus HV and/or PP groups of outpatients).
In conclusion, our findings show a high prevalence of b-lactam (44%) and MLS (29%) resistance genes in human oral Capnocytophaga species. We also describe for the first time the distribution of the new class A b-lactamase gene, bla CSP-1 , only in a subgroup of C. sputigena species and characterize the erm(F) and erm(C) genes incriminated in MLS resistance in Capnocytophaga spp.
Nucleotide sequence accession numbers
The complete erm(F) and partial erm(C) nucleotide sequences from C. sputigena Be58 and C. ochracea Bi75 isolates, respectively, have been deposited in GenBank under accession numbers JQ707297 and JQ886176.
